Latest Director Changes News

Iperion reported a lower loss for the year ended 31 March 2026, but its cash reserves and net assets fell sharply, leaving the NZX-listed materials company reliant on related-party funding and director support. Its Pathoglaze manufacturing operation is also being moved from Malaysia to Singapore while customer trials continue.

Prestal Holdings Limited posted a 30% drop in sales to $10.3 million and a $3.6 million net loss for FY26, while exiting its core Hampers With Bite business in a strategic pivot.

Australian Ethical Investment Ltd posted record FY26 results with a 29% rise in net profit after tax and funds under management reaching $14.5 billion, driven by strong superannuation inflows and growth in private markets.

Supply Network Limited reported a 15.4% rise in FY2026 revenue to $403.7 million and a 19% jump in net profit to $47.6 million, underpinning a 44-cent fully franked final dividend. The company is advancing major branch expansions and IT upgrades to support its $50 million revenue growth target for FY2027.

nib Group reported a 6.2% revenue increase to $3.8 billion and a 9.1% rise in underlying operating profit to $260.9 million for FY26, despite a 5.9% net profit dip. The company achieved maiden profitability in Health Services and declared a fully franked 21c dividend including a 5c special, supported by ongoing Travel insurance divestments.

Qualitas Real Estate Income Fund (ASX: QRI) posted a 6% rise in operating profit to $70.9 million for FY26, driven by portfolio growth and rising interest rates. The Trust raised $34.6 million via an entitlement offer to expand its mortgage-backed loan portfolio, maintaining stable distributions despite a modest unit price discount to NAV.

NextEd Group navigated a tough international education market in FY26, boosting underlying EBITDA by 7% to $15.3 million even as revenue fell 6.7%. A $13 million goodwill impairment weighed on net losses, but ongoing cost discipline and vocational course growth underpin a resilient platform.

Rhythm Biosciences bolstered its financial position with a $5.2 million option underwriting while accelerating commercial adoption of its ColoSTAT® colorectal cancer test and advancing geneType™ partnerships internationally in Q4 FY26.

Iperion Limited trimmed its net loss to $294,595 for the year to March 2026, aided by waived manufacturing fees and waived licence performance targets, while securing a $250,000 loan facility to underpin ongoing development of its antimicrobial Pathoglaze product.

Regener8 Resources is transitioning its leadership as founder Stephen Foley steps down, paving the way for a new Managing Director with regional operational expertise to steer the company’s next exploration phase in Bosnia and Herzegovina.

Xenora Minerals has committed to the next stage of its Dudley Lithium Project earn-in, revealing new lithium anomalies using enhanced soil sampling techniques. Meanwhile, the company navigates a key leadership change with a new managing director appointed.

Metrics Real Estate Multi-Strategy Fund has reported a striking increase in half-year profit and distributions, underpinned by strong commercial real estate investments across debt and equity portfolios.